当前位置: 首页 >> 检索结果
共有 40987 条符合本次的查询结果, 用时 1.9084825 秒

861. Chronic PPI use after anti-reflux surgery: a retrospective observational pilot study.

作者: J W Van Dam.;L M Van den Dop.;G Van den Brink.;M W M De Waal.;J C Kiefte-de Jong.;M E Numans.;W E Hueting.
来源: BMC Gastroenterol. 2025年25卷1期710页
Chronic Proton Pump Inhibitor (PPI) use after anti-reflux surgery (ARS) remains common. Which patient factors contribute to chronic PPI use after surgery is unclear. The primary aim was to provide a long-term outcome of ARS by evaluating PPI use in the years after surgery and identify determinants of chronic PPI use after surgery.

862. Global burden of acute pancreatitis attributable to high alcohol intake from 1990 to 2021: findings and prevention potential based on GBD 2021.

作者: Wenchi Liu.;Ting Yan.;Jun Lin.;Qiaoyi Wu.;Xing Yu.
来源: BMC Gastroenterol. 2025年25卷1期716页
Although recent studies have examined alcohol-attributable pancreatitis (AAP), the contributions of population growth, aging, and sociol demographic index (SDI)disparities remain insufficiently quantified.This study aimed to assess the global, regional, and national burden of alcohol-related AP from 1990 to 2021, evaluating trends across socioeconomic and demographic strata to inform policy making.

863. The role of peripheral blood cell analysis-derived inflammatory parameters in predicting malignant duodenal stenosis.

作者: Palidanguli Pata'er.;Shanshan Liu.;Jiawei Chen.;Qi He.;Guochen Shang.;Yu Jin.;Jun Liu.;Chaoqun Han.;Shi Liu.
来源: BMC Gastroenterol. 2025年25卷1期713页
The unique location and complex anatomical structure of the duodenum poses challenges for the application of endoscopic biopsy. Differentiating benign and malignant duodenal stenosis remains difficult for clinicians. Therefore, there is an urgent need for a new, reliable, and cost-effective biomarker to differentiate between benign and malignant duodenal stenosis.

864. Evaluation of the direct cost of chronic viral hepatitis B in patients monitored at the hepato-gastroenterology department of the Yalgado OUEDRAOGO University Hospital.

作者: Karim Ouedraogo.;Amadou Oury Toure.;Fadima Yaya Bocoum.;Djenabou Diallo.;Alexandre Delamou.;Seni Kouanda.
来源: BMC Gastroenterol. 2025年25卷1期717页
Chronic viral hepatitis B constitutes a public health problem due to its morbidity, mortality and economic consequences. To date, the direct costs incurred by patients for the treatment of this condition are not well documented. Our study aims to provide evidence on this cost in order to help facilitate patient care and optimize national hepatitis control policies.

865. Melatonin alleviates diarrhea and visceral hypersensitivity in rats with diarrhea-predominant irritable bowel syndrome by modulating of the TLR4/MyD88/NF-κB pathway.

作者: Zuohui Yuan.;Xiaoping Yang.;Xiaochun Wang.;Xinlong Shi.;Jia Chen.;Lijun Huang.;Jie Yang.;Yuping Shi.;Liping Zhang.;Ping Mai.
来源: BMC Gastroenterol. 2025年25卷1期715页
This study aimed to investigate the effects of melatonin on diarrhea and visceral hypersensitivity in rats with diarrhea-predominant irritable bowel syndrome (IBS-D) and to explore its potential mechanisms through modulation of the TLR4/MyD88/NF-κB pathway.

866. Elucidating the role of IgA plasma cells and PECAM1-CD38 interaction in intestinal fibrosis: a single-cell RNA sequencing analysis in Crohn's disease.

作者: Shuyang Sun.;Jiheng Wang.;Kai Li.;Hua Jin.;Shuwen Du.;Jingyan Feng.;Limin Zhang.;Lei Li.;Yuqi He.
来源: BMC Gastroenterol. 2025年25卷1期712页
Intestinal fibrosis-associated stricture is a frequent complication of inflammatory bowel disease (IBD), often necessitating endoscopic or surgical interventions. This study aims to investigate the pathogenesis of fibrosis in Crohn's disease (CD), a type of IBD, by analyzing single-cell RNA sequencing (scRNA-Seq) data from colon biopsies of both CD and ulcerative colitis (UC) patients.

868. ICD-10 code validation for gastrointestinal bleeding in patients receiving oral anticoagulation: nationwide cohort study.

作者: Arnar Bragi Ingason.;Jóhann Páll Hreinsson.;Arnar Snær Ágústsson.;Sigrún Helga Lund.;Edward Rumba.;Sigríður Kristjánsdóttir.;Einar Stefán Björnsson.
来源: BMC Gastroenterol. 2025年25卷1期706页
ICD-10 codes are commonly used to identify gastrointestinal bleeding (GIB) events in observational studies. However, most studies have neither used validated ICD-10 coding algorithms to identify GIB events nor manually confirmed the diagnosis of GIB, which raises concerns regarding the validity of their results. The aim of the study was to estimate the accuracy of ICD-10 codes for GIB in patients receiving oral anticoagulation and to develop new coding algorithm for identifying GIB events.

869. Associations of urinary iodine concentration (UIC) with Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) among non-diabetic population: analysis of the NHANES 2017-2020.

作者: Zhaoguang Chen.;Jianfeng Yu.;Yanbin Wang.;Donglei Zhang.;Jianyu Hao.;Xinjuan Liu.
来源: BMC Gastroenterol. 2025年25卷1期705页
Metabolic dysfunction-associated steatotic liver disease(MASLD) and diabetes are manifestations of metabolic syndrome. Urinary iodine concentration (UIC) is closely related to diabetes and glucose metabolism, but studies on the relationship between UIC and MASLD in non-diabetic individuals are limited. Our purpose was to explore the associations between UIC and MASLD as well as liver fibrosis in the non-diabetic population.

870. Upadacitinib induction therapy in Crohn' s disease: a retrospective real-world study in biologic-refractory patients.

作者: Xiaoyu Fu.;Lei Tu.;Yu Fu.;Huan Wang.;Yidong Chen.;Xiaopeng Zhang.;Qi Yu.;Fang Liu.;Yiyu Cheng.;Jiamin Li.;Qianxi Xia.;Rong Lin.;Liangru Zhu.
来源: BMC Gastroenterol. 2025年25卷1期707页
Upadacitinib, a selective Janus kinase 1 (JAK1) inhibitor, has demonstrated efficacy in clinical trials for Crohn's disease (CD) but real-world evidence remains limited. This study aimed to evaluate the effectiveness and safety of upadacitinib as induction therapy in a Chinese cohort with active CD.

871. Development and validation of a machine learning-based prediction model for prolonged length of stay after laparoscopic gastrointestinal surgery: a secondary analysis of the FDP-PONV trial.

作者: Jiankun Shi.;Yabin Huang.;Jiaxin Han.;Shimin Zhang.;Xingshan Cheng.;Tongfeng Luo.
来源: BMC Gastroenterol. 2025年25卷1期703页
Prolonged postoperative length of stay (PLOS) is associated with several clinical risks and increased medical costs. This study aimed to develop a prediction model for PLOS based on clinical features throughout pre-, intra-, and post-operative periods in patients undergoing laparoscopic gastrointestinal surgery.

872. Retrospective study: analysis of risk factors and construction of prediction model for pancreatic steatosis.

作者: Wanli Zan.;Jingxin Yang.;Yi Zhou.
来源: BMC Gastroenterol. 2025年25卷1期708页
Pancreatic steatosis, closely related to various metabolic diseases has no unified standard for the diagnosis. The purpose of this study was to construct and validate a risk prediction model of pancreatic steatosis.

873. A Notch signal pathway related gene signature predicts overall survival in colorectal cancer.

作者: Mingyou Dong.;Zhihao Ding.;Xinyi Liang.;Meng Gao.;Mengqi Fan.;Xueying Peng.;Lusheng Liao.;Xiaodong Zhang.
来源: BMC Gastroenterol. 2025年25卷1期704页
Colorectal cancer (CRC) is a prevalent malignancy worldwide, characterized by high morbidity and mortality rates. The notch signaling pathway plays a dual role as both a tumor suppressor and promoter during embryonic development. However, the precise role and underlying mechanisms of notch signal pathway-related genes in CRC remain unclear.

874. The pathobiont role of Akkermansia muciniphila in colorectal cancer: a systematic review.

作者: Maryam Soheilipour.;Ali Noursina.;Mohadese Nekookhoo.;Elena Malekpour.;Seyed Arsham Mirzaei.;Mohammad Hossein Shafieyoun.;Hanieh Rouzbahani.;Mohammad Reza Chitsazi.;Farzad Safari.
来源: BMC Gastroenterol. 2025年25卷1期702页
Colorectal cancer (CRC) is the second leading cause of cancer-related mortality worldwide. Emerging evidence highlights the gut microbiota, particularly Akkermansia muciniphila, as a key modulator in CRC pathogenesis. While often regarded as a beneficial commensal, its role in CRC appears complex and potentially dualistic.

875. Translating Population-Based Evidence on Helicobacterpylori Eradication Into Precision Surveillance Strategies.

作者: Yasutoshi Shiratori.;Naoki Ishii.;Anthony Kalloo.
来源: Gastroenterology. 2026年170卷2期425-426页

876. Reassessing the Observational Evidence for Helicobacterpylori Eradication and Gastric Cancer Prevention.

作者: Jiajie Lu.;Li Huang.
来源: Gastroenterology. 2026年170卷2期423-424页

877. Cautious Implementation of Helicobacter pylori Eradication in the Elderly.

作者: Changlong Yang.;Zhiyu Shi.;Ce Zhang.
来源: Gastroenterology. 2026年170卷3期654-655页

878. Comments on "Preventive Effect of Helicobacter pylori Treatment on Gastric Cancer Incidence and Mortality: A Korean Population Study".

作者: Xiaoyu Tang.;Junkang Zhao.;Jingjin Hu.;Liyun Zhang.;Dan Ma.
来源: Gastroenterology. 2026年170卷2期424-425页

879. Mass Screening of Celiac Disease: A Crossing Point Between Secondary and Primary Prevention?

作者: Marisa G Stahl.;Maureen M Leonard.;Edwin Liu.;Maria Ines Pinto-Sanchez.;Gideon Lack.;Carlo Catassi.
来源: Gastroenterology. 2026年170卷2期240-245页

880. Foundation Models in Medicine, Gastroenterology, and Endoscopy: The Next Frontier?

作者: Laya Rafiee Sevyeri.;Daniel von Renteln.
来源: Gastroenterology. 2026年170卷1期16-18页
共有 40987 条符合本次的查询结果, 用时 1.9084825 秒